Olivier Leger
64Patents
13h-index
66Co-inventors
87Inventor score
Filing activity: Nov 21, 1995 → Sep 29, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7728114B2 | Anti-CD3 antibodies and methods of use thereof | Chemistry; Metallurgy | 174 | Active |
| US5840299A | Humanized antibodies against leukocyte adhesion molecule VLA-4 | Chemistry; Metallurgy | 156 | Expired |
| US6455677B1 | FAP&agr;-specific antibody with improved producibility | Chemistry; Metallurgy | 84 | Expired |
| US7241444B2 | Anti-IGF-IR antibodies and uses thereof | Emerging Cross-Sectional Technologies | 54 | Expired |
| US8246958B2 | Methods of inhibiting alpha-4-dependent interactions with VCAM-1 with anti-VLA-4 antibodies | Physics | 53 | Active |
| US8609822B2 | Neutralizing antibodies and methods of use thereof | Chemistry; Metallurgy | 48 | Active |
| US9624298B2 | Anti-PD-L1 antibodies and uses thereof | Chemistry; Metallurgy | 45 | Active |
| US8715669B2 | Anti-IL-17A/IL-17F cross-reactive antibodies | Chemistry; Metallurgy | 23 | Active |
| US10487147B2 | Anti-PD-L1 antibodies and uses thereof | Chemistry; Metallurgy | 17 | Active |
| US10280226B2 | Anti-GITR antibodies and methods of use thereof | Emerging Cross-Sectional Technologies | 14 | Active |
| US10155818B2 | Anti-GITR antibodies and methods of use thereof | Emerging Cross-Sectional Technologies | 14 | Active |
| US7700098B2 | Anti-interferon gamma antibodies and methods of use thereof | Chemistry; Metallurgy | 14 | Active |
| US10301384B2 | Antibodies to IL-15 | Emerging Cross-Sectional Technologies | 14 | Active |
| US7674884B2 | Neutralizing antibodies and methods of use thereof | Chemistry; Metallurgy | 12 | Active |
| US7435802B2 | Humanized anti-VLA4 immunoglobulins | Physics | 11 | Expired |
| US10836830B2 | Antibodies and methods of use thereof | Chemistry; Metallurgy | 9 | Active |
| US7553485B2 | Anti-IGF-IR and/or anti-insulin/IGF-I hybrid receptors antibodies and uses thereof | Chemistry; Metallurgy | 9 | Expired |
| US7786268B2 | Anti-IP-10 antibodies and methods of use thereof | Chemistry; Metallurgy | 8 | Active |
| US9682142B2 | Anti-interferon gamma antibodies and methods of use thereof | Chemistry; Metallurgy | 7 | Active |
| US8551478B2 | Anti-CD3 antibodies and methods of use thereof | Chemistry; Metallurgy | 6 | Active |
| US8771697B2 | Methods of treatment using anti-IL-17A/IL-17F cross-reactive antibodies | Chemistry; Metallurgy | 6 | Active |
| US8034344B2 | Anti-IL-6/IL-6R antibodies and methods of use thereof | Chemistry; Metallurgy | 5 | Active |
| US7914784B2 | Anti-IGF-IR antibodies and uses thereof | Emerging Cross-Sectional Technologies | 4 | Active |
| US9850304B2 | Anti-CD3 antibodies and methods of use thereof | Chemistry; Metallurgy | 4 | Active |
| US8546539B2 | Fc receptor-binding polypeptides with modified effector functions | Chemistry; Metallurgy | 3 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.